PPD, Inc. is opening a new lab in Suzhou, China, to support China-based biopharma companies and Western pharmaceutical companies managing research studies in China. The 67,000-sq.-ft. facility is expected to be fully operational in 2021, offering bioanalytical, biomarker and vaccine services to support trials across all phases of pharmaceutical development. The company anticipates adding approximately 350 positions as a result of the expansion.    The bioanalytical lab offering in Suzhou...